Quartz Partners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.46M Sell
34,861
-133
-0.4% -$19.9K 1.79% 19
2026
Q1
$5.35M Sell
34,994
-388
-1% -$59.5K 2.07% 13
2025
Q4
$4.88M Buy
35,382
+2,970
+9% +$389K 1.82% 19
2025
Q3
$4.16M Buy
32,412
+7,330
+29% +$894K 1.51% 23
2025
Q2
$3.04M Sell
25,082
-137
-0.5% -$15.4K 1.39% 21
2025
Q1
$2.81M Buy
25,219
+7,056
+39% +$751K 1.71% 17
2024
Q4
$1.77M Buy
18,163
+853
+5% +$91K 1.08% 24
2024
Q3
$1.99M Buy
+17,310
New +$1.96M 1.25% 19

Other funds holding NVS

Quartz Partners's NVS Position: Q2 2026 in Review

Quartz Partners reduced its Novartis (NVS) stake by 0.38% in Q2 2026, selling an estimated $19.9K and leaving 34,861 shares worth $5.46M. The position accounts for 1.79% of the portfolio, ranked #19.

Quartz Partners first reported a position in NVS in Q3 2024 and has held it in 8 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Quartz Partners held 34,861 shares of Novartis worth $5.46M as of Q2 2026.
  • Quartz Partners sold 133 Novartis shares in Q2 2026, an estimated $19.9K.
  • Novartis made up 1.79% of Quartz Partners's portfolio in Q2 2026, its #19 holding.
  • Quartz Partners first reported a position in Novartis in Q3 2024 and has held it in 8 quarters since.
  • 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Quartz Partners's 13F filing for Q2 2026, filed 10 Aug 2026.